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Abstract
Background: Polyketides (PKs) and non-ribosomal peptides
(NRPs) are therapeutically important natural products biosynthe-
sized by multimodular protein assembly lines, termed the PK
synthases (PKSs) and NRP synthetases (NRPSs), via a similar
thiotemplate-mediated mechanism. The potential for productive
interaction between these two parallel enzymatic systems has
recently been demonstrated, with the discovery that PK/NRP
hybrid natural products can be of great therapeutic importance.
One newly discovered PK/NRP product, epothilone D from
Sorangium cellulosum, has shown great potential as an anti-tumor
agent.
Results : The chain-initiating methylthiazole ring of epothilone
has been generated in vitro as an acyl-S-enzyme intermediate,
using five domains from two modules of the polymodular
epothilone synthetase. The acyl carrier protein (ACP) domain,
excised from the EpoA gene, was expressed in Escherichia coli,
purified as an apo protein, and then post-translationally primed
with acetyl-CoA using the phosphopantetheinyl transferase
enzyme Sfp. The four-domain 150-kDa EpoB subunit (cycliza-
tion^adenylation^oxidase^peptidyl carrier protein domains: Cy^
A^Ox^PCP) was also expressed and purified in soluble form from
E. coli. Post-translational modification with Sfp and CoASH
introduced the HS-pantP prosthetic group to the apo-PCP,
enabling subsequent loading with L-cysteine to generate the Cys-
S-PCP acyl enzyme intermediate. When acetyl-S-ACP (EpoA) and
cysteinyl-S-EpoB were mixed, the Cy domain of EpoB catalyzed
acetyl transfer from EpoA to the amino group of the Cys-S-EpoB,
generating a transient N-Ac-Cys-S-EpoB intermediate that is
cyclized and dehydrated to the five-membered ring methylthiazo-
linyl-S-EpoB. Finally, the FMN-containing Ox domain of EpoB
oxidized the dihydro heterocyclic thiazolinyl ring to the hetero-
aromatic oxidation state, the methylthiazolylcarboxy-S-EpoB.
When other acyl-CoAs were substituted for acetyl-CoA in the
Sfp-based priming of the apo-CP domain, additional alkylthiazo-
lylcarboxy-S-EpoB acyl enzymes were produced.
Conclusions: These experiments establish chain transfer across a
PKS and NRPS interface. Transfer of the acetyl group from the
ACP domain of EpoA to EpoB reconstitutes the start of the
epothilone synthetase assembly line, and installs and converts a
cysteine group into a methyl-substituted heterocycle during this
natural product chain growth. ß 2001 Elsevier Science Ltd. All
rights reserved.
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1. Introduction
Both polyketide (PK) and non-ribosomal peptide (NRP)
natural products are constructed on thiotemplated multi-
modular protein assembly lines [1,2], termed the PK syn-
thases (PKS) and NRP synthetases (NRPS), respectively.
In these protein assembly lines the inventory and place-
ment of catalytic and carrier domains in the modules dic-
tate the selection and sequence of acyl and aminoacyl
monomers incorporated into the growing natural product
chains. Some of the most therapeutically interesting mem-
bers of these natural product classes are PK/NRP hybrids,
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such as the immunosuppressant drugs FK506 and rapa-
mycin [3,4], the widely used anticancer chemotherapeutic
agent bleomycin [5] and, most recently discovered, epothi-
lone D (Fig. 1b), now undergoing clinical trials for oncol-
ogy. Sequence analysis of the epothilone biosynthetic gene
cluster [6,7] from the producer organism Sorangium cellu-
losum reveals a hybrid assembly line (Fig. 1a), with the
EpoA, C, D, E, and F subunits comprising a PKS array
of a loading module (EpoA) followed by eight extender
modules (EpoC^F). The second subunit EpoB has four
domains reminiscent of an NRPS module, cyclization
(Cy)^adenylation (A)^oxidase (Ox)-peptidyl carrier pro-
tein (PCP), and, interspersed between EpoA and EpoC
PKS subunits, is appropriately placed to create the thia-
zole ring of epothilones [6,7]. It is anticipated that the
interface between the EpoA and EpoB subunits is a switch
point between PKS-type Claisen chemistry and NRPS-
type peptide chemistry (Fig. 1c). The EpoB and EpoC
interface correspondingly switches the assembly line logic
back from NRPS to PKS for modules 2^9 for construc-
tion of the 16-membered macrolactone ring moiety (Fig.
1b).
In this work we have expressed and puri¢ed the acyl
carrier protein (ACP) domain of the EpoA subunit and
the full-length EpoB subunit in Escherichia coli, have en-
zymatically loaded the former with an acetyl group, the
latter with a cysteinyl group, and detected chain transfer,
condensation, cyclization/dehydration, and oxidation to
build a methylthiazolylcarboxy-S-EpoB acyl enzyme inter-
mediate reconstituting the PKS/NRPS switch point and
the start of the epothilone synthetase assembly line.
When various acyl-CoAs are used in place of acetyl-
CoA, a series of alkylthiazoles are formed as covalent
acyl-S-enzymes on the EpoB subunit.
2. Results
2.1. Heterologous expression and puri¢cation of the
ACP domain of the EpoA subunit and the
full-length EpoB subunit
Initial e¡orts to express the 150-kDa four domain EpoA
subunit of the S. cellulosum in E. coli produced inactive
protein under various growth conditions. We therefore
focused on the expression of the C-terminal ACP domain
of EpoA (Fig. 1c). Sequence alignment with other ACP
domains (EpoD, EpoE, MtaF, McyD, NysC) [6^10] using
the BLAST algorithm led us to predict the domain bound-
ary and express the ACP domain alone (residues 1286^
1421) as a 136-residue fragment of 14.5 kDa. Included in
the fragment was the proposed linker region connecting
the ACP domain with the C-terminal portion by which the
ACP domain is thought to interact with the N-terminal
portion of EpoB protein [11]. Expressed with an N-termi-
nal His6 tag, this protein was soluble and readily puri¢ed
by nickel a⁄nity chromatography as shown in Fig. 2A,
with a yield of 5 mg/l. Relatively short induction times
        
Fig. 1. (a) The epothilone biosynthetic gene cluster from S. cellulosum. Genes epoA, epoB, and epoC whose gene products represent the PKS/NRPS/
PKS interfaces are highlighted in color. The colors of the genes are coded to follow the pieces they incorporate into epothilones. (b) Epothilone natural
products include epothilone A, B, C, and D and among them epothilone D is the most promising anticancer drug candidate whose chemical structure
is shown. (c) Domain organization of EpoA, EpoB, and EpoC with the putative substrates covalently docked onto the carrier protein moiety. KSy de-
notes a mutation of a critical active site residue cysteine to tyrosine in EpoA KS.
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(3 h at 24‡C) minimized the degree of post-translational
phosphopantetheine (pantP) modi¢cation of the ACP do-
main by the E. coli phosphopantetheinyl transferase
(PPTase) ACPS [12,13] ensuring that the apo form of
the ACP domain was isolated. HPLC analysis (Fig. 2B,
trace a) and matrix-assisted laser desorption ionization
mass spectrometry (MALDI-MS) (Table 1) con¢rmed
pure apo-ACP protein ([M+H] observed, 16 530; pre-
dicted, 16 527).
Puri¢cation of full-length 150-kDa four domain EpoB
also involved an N-terminal His tag strategy. Expression
conditions were optimized to give detectable soluble EpoB
that could be puri¢ed on a Ni^NTA column, followed by
MonoQ and size exclusion chromatographic steps (Fig.
3A) with a protein yield of 1.5 mg per liter of cell culture.
The puri¢ed EpoB protein is noticeably yellow and shows
characteristic absorbance of a £avin cofactor in its UV^vis
spectrum (Fig. 3B). This was identi¢ed as FMN by coelu-
tion with authentic standard on HPLC analysis after heat
denaturation of the protein. The A279=441 ratio of 9.8/1 is
consistent with essentially stoichiometric cofactor loading
of the EpoB subunit. We could separately express just the
27.9-kDa Ox domain of EpoB and also purify it as an
FMN-containing fragment (data not shown).
2.2. Post-translational priming of the apo-ACP domain of
EpoA by the PPTase Sfp with CoA or acetyl-CoA to
yield HS-pantP-ACP or acetyl-S-pantP-ACP
Ser1345 of the ACP domain is located within the con-
sensus sequence GMDSLM for post-translational phos-
phopantetheinylation. In the absence of the S. cellulosum
PPTase that would perform the normal post-translational
priming reaction, we utilized the PPTase from the surfac-
tin biosynthetic operon of B. subtilis as a versatile priming
catalyst [14,15]. The HPLC trace b in Fig. 2B shows the
quantitative conversion of the pure apo-ACP to the holo
form and Table 1 validates the expected gain of 340 mass
units of the pantP group. However, since we removed the
ketosynthase (KS) and acyltransferase (AT) modules that
normally derivatize the phosphopantetheinyl moiety with
an acyl group, the HS-holo form of this ACP domain
could not be utilized in the experiments described below.
Instead, the acetyl-S-pantP-ACP derivative was generated
using the strategy illustrated in Eq. 1:
                                                                                     
               
Fig. 2. (A) Analysis of the puri¢cation of EpoA-ACP by nickel a⁄nity chromatography (15% SDS^PAGE). Lane 1, molecular weight markers; lane 2,
crude cell extract ; lane 3, puri¢ed ACP protein. (B) HPLC analysis of various EpoA-ACPs. (a) apo-ACP as puri¢ed from E. coli ; (b) holo-ACP re-
sulted from Sfp modi¢cation of the apo-ACP with free CoA. (c) Acetyl-S-ACP obtained by Sfp modi¢cation of the apo-ACP with acetyl-CoA.
Table 1
MALDI-TOF mass analysis of ACP loaded with di¡erent acyl groups
ACPs Calculated [M+H] Observed [M+H]
apo-ACP 16527 16530
holo-ACP 16867 16870
Acetyl-S-ACP 16909 16911
Propionyl-S-ACP 16925 16926
Butyryl-S-ACP 16939 16948
Isobutyryl-S-ACP 16939 16946
Isovaleryl-S-ACP 16953 16959
Hexanoyl-S-ACP 16967 16969
Benzoyl-S-ACP 16973 16977
Acetoacetyl-S-ACP 16953 16957
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by taking advantage of our previous ¢ndings that Sfp will
accept not only CoASH as substrate but also various acyl-
CoAs [14,15].
In this case, the acetyl-S-pantP group is transferred
onto the side chain of Ser1345 to generate the acyl thio-
ester form of the holo-ACP. Thus, the autoradiography
(Fig. 4A) shows that the apo-ACP can be covalently modi-
¢ed to the holo form by Sfp and [3H]CoA (lane 3) or to
the [3H]acetyl-S-ACP (lane 5) by instead using [3H]acetyl-
CoA as priming substrate. Fig. 4B shows a time course for
the covalent loading of [3H]acetyl-S-pantP moiety onto
the apo-ACP, with a calculated fractional stoichiometry
of loading of 70%. Finally, when the acetyl-S-pantP prim-
ing was repeated with unlabeled acetyl-CoA, HPLC anal-
Fig. 3. (A) 10% SDS^PAGE analysis of the protein samples collected from di¡erent steps during EpoB puri¢cation. Lanes 1 and 6, molecular weight
markers; lane 2, crude extract ; lane 3, Ni^NTA a⁄nity chromatography; lane 4, FPLC-MonoQ; lane 5, Size exclusion chromatography. (B) UV^vis
spectrum of the puri¢ed EpoB protein. This spectrum displays three absorption maxima at 279 nm, 349 nm, and 441 nm, reminiscent of a £avin-con-
taining protein. Inset shows the expanded 300^550 nm region to illustrate the ¢ngerprint ¢ne structure of the bound £avin cofactor.
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ysis of the reaction mixture shows almost quantitative
loading of acetyl group (Fig. 2B, trace c). MALDI-MS
analysis of the reaction mixture showed an increase of
41 mass units (expected 42 for an acetyl group) compared
to the HS-pantP-ACP, con¢rming the covalent loading of
an acetyl group (Table 1).
2.3. Characterization of the A and PCP domains of the
EpoB subunit
The NRPS-type EpoB subunit is predicted to have four
domains, Cy^A^Ox^PCP, two of which, the A domain
and the PCP domain, could be assayed for activity in
the puri¢ed EpoB subunit alone. Given the presence of
the thiazole in the epothilone natural product, the A do-
main is predicted to activate L-Cys to the L-Cys-AMP.
This expectation is validated by the amino acid depen-
dency and speci¢city of the 32PPi^ATP exchange reaction,
which is a classic measure of reversible formation of en-
zyme-bound aminoacyl-AMP [16]. The EpoB A domain
was selective both for the chirality of K-carbon and prop-
erties of the side chain group. Results for the substrate-
dependent PPi^ATP exchange reaction catalyzed by EpoB
are shown in Fig. 5 and Table 2. Amino acids L-Ala,
L-Asp, D-Cys, L-Cys, L-Leu, L-Lys, L-Phe, L-Ser, L-Thr,
and (S)-2-aminobutyrate were examined. Several of these
substrates failed to produce detectable signal. The relative
selectivity of some representative substrates is shown in
Fig. 5. Only L-Cys, L-Ser, and (S)-2-aminobutyrate were
su⁄ciently active for the kinetic measurements and the
results are shown in Table 2.
The activated Cys-AMP is expected to be captured in-
tramolecularly by the HS-pantetheinyl arm of the holo-
PCP domain of EpoB to covalently install the cysteinyl
moiety. Conversion of apo to holo form of the PCP do-
main of EpoB was achieved by the same strategy of post-
translational modi¢cation used on the apo-ACP domain
of the EpoA subunit above with CoA and the Sfp PTTase
(data not shown). Then, the covalent auto-aminoacylation
                              
                                 
Fig. 4. (A) Coomassie brilliant blue-stained 15% SDS^PAGE gel analysis of Sfp-catalyzed post-translational modi¢cation and corresponding autoradio-
gram of EpoA-ACP samples. Lane 1, molecular weight markers; lane 2, ACP+[3H]CoA3Sfp; lane 3, ACP+[3H]CoA+Sfp; lane 4, ACP+[3H]acetyl-
CoA3Sfp, lane 5, ACP+[3H]acetyl-CoA+Sfp. (B) Time course of the post-translational modi¢cation of ACP by PPTase Sfp with [3H]acetyl-CoA.
Fig. 5. Adenylation speci¢city of the EpoB A domain. The incorpora-
tion of [32P]PPi into ATP was assessed by the ATP^PPi exchange as-
says. (S)-2-AB = (S)-2-aminobutyrate. L-Ala, L-Asp, L-Leu, and L-Lys,
and L-Phe were also examined but all of them failed to show detectable
activity (data not shown).
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of holo EpoB subunit by [35S]Cys was readily detected by
autoradiography after SDS gel electrophoresis (Fig. 6).
The Cys-S-enzyme formation is dependent on ATP (lanes
3 and 4 on the autoradiogram) and prior priming by Sfp
(lane 2). A small amount of labeling in the absence of Sfp
most likely re£ects a small fraction of holo EpoB, presum-
ably resulting from the action of an indigenous E. coli
PPTase [13] under the particular overexpression conditions
used here for EpoB. Trichloroacetic acid (TCA) precipita-
tion assays were used to analyze the time course of auto
cysteinylation, which was shown to be a rapid process and
L-Cys reached its ¢nal stoichiometry of 82% within a min-
ute (data not shown).
2.4. Transfer of the [3H]acetyl group from
[3H]acetyl-S-ACP to cysteinyl-S-EpoB:
[3H]methylthiazolylcarboxy-S-enzyme formation
With [3H]acetyl-S-ACP and cysteinyl-S-EpoB acyl en-
zyme forms in hand, the intersubunit transfer of the acetyl
group, across the PKS/NRPS interface, could be examined
by monitoring transfer of the radioactive acetyl group
from the EpoA-ACP to the EpoB subunit. As shown in
Fig. 7A, an autoradiogram clearly indicates [3H]acetyl-
containing EpoB after incubation with [3H]acetyl-ACP
of EpoA. This transfer is dependent on ATP (lane 3)
and on cysteine (lane 4) and is speci¢c for the acetyl-S-
ACP as donor, since acetyl-CoA will not substitute up to
concentration of 5 mM (data not shown). Although this
substrate transfer experiment clearly establishes the con-
densation function of the Cy domain, the cyclization/de-
hydration function of the Cy domain of EpoB remained
unclear, requiring a separate assay to establish whether the
acylated form of EpoB was the acyclic N-acetyl-Cys-S-
EpoB, or the heterocyclized methylthiazolinyl-S-EpoB.
Also, the function of a putative Ox domain in EpoB
would be con¢rmed if the ¢nal product was the two-elec-
tron oxidized heterocyclic methylthiazolylcarboxy-S-
EpoB. The reactions were repeated with [35S]cysteine as
the labeled EpoB substrate, the acyl thioester linkage(s)
in the acyl-EpoB enzyme were hydrolyzed by 0.1 M
KOH treatment, and the released small molecule was sub-
jected to HPLC analysis and the results are shown in Fig.
7B. The [35S]Cys peak (retention time (rt) = 4.5 min) was
almost undetectable, and instead a single radioactive peak
(rt = 14.3 min) was observed. When coinjected with the
chemically prepared standards, this 35S-associated product
peak comigrated with 2-methylthiazolyl-4-carboxylic acid.
Neither the acyclic N-acetyl-Cys nor the methylthiazolinyl
intermediate was detected, indicating that cyclization/de-
hydration activity of the Cy domain of EpoB as well as the
FMN-dependent Ox domain acting as a thiazoline oxidase
are fully functioning. The identity of the enzymatic prod-
uct was further con¢rmed by mass analysis, MALDI-time-
of-£ight (-TOF) of the HPLC puri¢ed material from the
EpoB incubation to be methylthiazolyl carboxylate
([M+H], C5H5NO2S, calculated, 144.01; observed,
143.98).
Table 2
Kinetic parameters of the ATP-[32]PPi exchange assays of the EpoB A domain
Substrate kcat (min31) Km (mM) kcat/Km (mM31min31)
L-Cysteine 54.9 þ 1.3 0.46 þ 0.04 119.3
S-2-Aminobutyrate 29.4 þ 0.4 8.0 þ 0.3 3.7
L-Serine 11.0 þ 0.2 45.1 þ 1.2 0.24
Fig. 6. Analysis of auto-aminoacylation of EpoB with [35S]L-cysteine by SDS gel electrophoresis and autoradiography. (a) Coomassie brilliant blue-
stained 10% SDS^PAGE gel. Lanes 1 and 5, molecular weight markers ; lane 2, control reaction omitting Sfp; lane 3, control reaction omitting ATP;
lane 4, full reaction. (b) Autoradiogram of this gel.
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2.5. Recognition of di¡erent acyl-S-ACPs by the Cy
domain of EpoB: Aryl- and alkylthiazolylcarboxy-S-
EpoB acyl enzyme formation
Given the successful use of the Sfp PPTase to load the
acetyl-S-pantetheinyl moiety onto the apoACP domain of
EpoA, we then tested several additional acyl-CoA deriva-
tives to produce the corresponding acyl-S-ACP species as
potential acyl donors in the condensation/heterocycliza-
tion/oxidation reactions carried out by the EpoB subunit.
As detailed in Table 1, the broad speci¢city of Sfp allowed
installation of propionyl, butyryl, and hexanoyl straight
chain acyl-S-pantP moieties as well as the branched chain
isobutyryl and isovaleryl thioesters. The L-keto-acetoace-
tyl-S-ACP and the aryl benzoyl-S-ACP were likewise con-
verted to a single species as demonstrated by HPLC anal-
ysis (data not shown) and by MALDI-MS analysis (Table
1). These acyl-S-ACP derivatives were then used singly as
donors to [35S]cysteinyl-S-EpoB. The small molecule prod-
ucts were cleaved from the acyl-S-EpoB and subjected to
HPLC analysis. Figure 8A shows the HPLC traces for
seven such reactions, where in every case a new radioactive
peak containing [35S]cysteine-derived label was detected.
To validate that the alkyl or aryl aromatic heterocycles
were generated, six standards of 2-substituted thiazolyl-
4-carboxylic acids have been synthesized according to
the reaction scheme outlined in Fig. 8B. HPLC coinjection
of these chemically prepared standards with the radioac-
tive products released from EpoB con¢rmed their identi-
ties and some selected chromatograms are shown in Fig.
8C. Clearly the Cy and the Ox domains of the EpoB sub-
unit will tolerate wide variety in the acyl donor presented
on the upstream partner ACP, allowing a set of substi-
tuted thiazolyl caps to be made in the epothilone assembly
line.
                                                               
 
Fig. 7. (A) Analysis of the [3H]acetyl group transfer from [3H]acetyl-S-ACP to EpoB by SDS gel electrophoresis and autoradiography. (a) 10% SDS^
PAGE of EpoB samples from various transfer experiments. Lanes 1 and 5, molecular weight markers; lane 2, full reaction containing [3H]acetyl-S-
ACP, ATP, L-Cys, holo EpoB; lane 3, control sample omitting ATP; lane 4, control sample omitting L-Cys. (b) Corresponding autoradiogram. (B)
HPLC analysis and identi¢cation of acetyl-S-ACP and [35S]Cys-S-EpoB incubation product released from the PCP domain of EpoB by KOH treatment.
(a) HPLC trace of the authentic standards added to radioactive reaction mixture as cold carriers which were monitored by an UV detector at 220 nm.
(b) Radio-HPLC trace of the same sample recorded simultaneously by an on-line radioactivity detector tuned for 35S.
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3. Discussion
The epothilone family of natural products has attracted
interest for its potent anti-tumor e¡ects [17,18], acting
analogously to taxol in blocking mitotic spindle progres-
sion by stabilization of microtubules [19,20]. The mainte-
nance of anti-tumor activity in multi-drug resistant and
taxol-resistant cell lines has highlighted interest in clinical
evaluation of epothilones and focused attention on the
epothilone biosynthetic pathway. The epothilone family
is a hybrid of PK and NRP building blocks, with one
NRPS-type subunit, EpoB, embedded in a ¢ve-subunit,
nine-module EpoA, C, D, E, F assembly line that creates
the 16-membered macrolactone PK. It seemed likely that
EpoB would be the key subunit in creation of the thiazole
moiety of the epothilones, given the existence of compa-
                                                               
                                                               
 
Fig. 8. (A) HPLC analysis of the acyl transfer reactions using various acyl groups loaded onto EpoA-ACP to serve as donor substrates for [35S]Cys-S-
EpoB. The reactions were quenched with 10% TCA and the pelleted proteins were treated with 0.1 M KOH to hydrolyze the thioester linkage to release
the small molecule products. The supernatant was then injected into HPLC to resolve radioactive species. The [35S]Cys peak (rt = 4.5 min) was almost
non-detectable and a single new [35S]Cys derived peak was observed for all the acyl donors tested. (B) General chemical synthetic scheme to obtain
acyl-Cys, heterocyclized thiazolinyl carboxylic acids, and the two electron oxidized thiazolyl carboxylic acids. (C) HPLC coinjections of some selected
synthetic standards with radioactive enzymatic reaction product. Dual on-line UV (at 254 nm) and radioactive detectors (tuned for 35S) were used to
monitor the standard and radioactive product simultaneously. UV-HPLC traces a, b, and c show the retention property of three selected standards
2-isopropyl-, 2-pentyl-, and 2-phenylthiazolyl-4-carboxylic acids, respectively, while radio-HPLC traces aP, bP, and cP show the corresponding enzymatic
reaction products which are coeluted with the standards. The rest enzymatic products were also con¢rmed to be the substituted thiazoles by same meth-
od (data not shown) except for the incubation of acetoacetyl-S-EpoA and EpoB whose standard has not been synthesized.
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rable Cy and A domains in synthetase modules for thiazo-
lines and thiazoles formation in other NRPS biosynthetic
clusters (pyochelin [21]) and NRP/PKS hybrids (yersinia-
bactin [22], bleomycin [5]). Given its placement in the
assembly line EpoB should accept an acyl donor from
the EpoA subunit and in turn donate the methylthiazole
moiety to the downstream PKS module in EpoC (Fig.
9B).
In this work we have focused on the EpoA and EpoB
subunits and the acyl chain transfer between the subunits
that constitutes the switch from PKS to NRPS assembly
line logic. The four domain EpoA subunit has attributes
of a prototypic initiation or loading module in a PKS
assembly line, KS^AT^enoyl reductase (ER)^ACP do-
mains, but two of the four, KS and ER, have mutations
in consensus sequences likely to cause deactivation. In
particular, the active site cysteine of the KS domain is
missing, typical for a chain-initiating KS that is defective
in condensation function but retains its ability to decar-
boxylate the malonyl-S-ACP [23]. The AT domain is pre-
dicted to specify malonyl CoA for loading onto the holo
HS-pant-ACP domain [6,7]. The net result of the three
functional domains should be to generate an acetyl-S-
ACP on the C-terminal domain of EpoA as donor to
the downstream EpoB module (Fig. 9A).
Our e¡orts to generate the Sorangium full-length EpoA
in soluble, active form by heterologous expression in E. coli
have not yet met with success, so we elected to bypass
the KS and AT domain requirements and isolate the
ACP domain of EpoA. A 14.5-kDa ACP fragment ex-
presses well in E. coli as a soluble protein. To enact the
bypass strategy and create the kinetically labile, thermo-
dynamically activated acetyl-S-ACP fragment, two issues
needed to be solved. The ¢rst issue was to produce the apo
form of ACP rather than the phosphopantetheinylated
holo form and the second was to concurrently install the
pantP prosthetic arm and the acetyl moiety e⁄ciently and
quantitatively. In our prior experience in expression of
heterologous ACP and PCP domains in E. coli
[13,15,24], we have repeatedly noted that the E. coli
PPTases are slow to post-translationally prime the foreign
ACP and PCP proteins, such that relatively short induc-
tion times yield largely apo form, as was the case with the
ACP domain excised from the EpoA subunit. The require-
ment for the apo rather than the HS-pantP-ACP holo
form was at the core of the strategy for the second step:
Fig. 9. (A) The EpoA is a PKS loading module of the epothilone biosynthetic machinery to provide the acetyl starter unit. The AT domain is proposed
to speci¢cally load a malonyl group on the C-terminal ACP domain, and the KSy domain in which the conserved active site cysteine is mutated to ty-
rosine would promote the decarboxylation reaction to give acetyl-S-EpoA. The ER domain is most likely to be non-functional. (B) Detailed reaction
mechanism of these transformations e¡ected by the NRPS module EpoB. The Cy domain is bifunctional catalyzing the acetyl group transfer across the
¢rst PKS/NRPS interface for C^N bond formation and the subsequent cyclization/dehydration to create the thiazolinyl thioester intermediate. The
FMN-containing Ox domain acts as an acyl 2,3-desaturase to give the heteroaromatic moiety which is ready to be passed on to the following PKS
module EpoC.
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to introduce the acyl-S-pantP moiety intact in a concerted
enzymatic transfer step. This was possible because our
earlier characterization of the Bacillus subtilis Sfp PPTase
[14,15] indicated that this enzyme would utilize a variety of
acyl-S-CoA derivatives and transfer the acyl-S-pantP moi-
ety intact to the carrier protein. Subsequent X-ray analysis
of Sfp [8] con¢rms that the cysteamine end of CoASH
pointing out into solution when bound by the PPTase,
suggesting that the acyl group is not involved in Sfp rec-
ognition. Indeed, the EpoA apo-ACP domain could be
quantitatively primed not only with acetyl-S-pantP but
with a variety of other acyl groups from acyl-S-CoA sub-
strates.
The key catalytic subunit in fashioning the heteroaro-
matic methyl thiazole ring system in the epothilones is the
four domain EpoB. Two of the four domains, A and PCP,
are conventional NRPS modules. The remaining two do-
mains, Cy and Ox domains, are not commonly found in
the NRPS assembly line. The enzymatic function of the
Ox domain has never been validated in any NRPS system
before, although a similar Ox domain from the bleomycin
cluster has been expressed and puri¢ed as an FMN-con-
taining protein [25]. Our ability to overexpress and isolate
from E. coli the soluble, full-length 150-kDa EpoB sub-
unit, loaded with FMN in the Ox domain, enabled vali-
dation of all four domain functions. The A domain, as
expected [6,7], is speci¢c for L-cysteine, making the Cys-
AMP and then tethering it in a thioester linkage to the
adjacent holo-PCP domain, to yield the Cys-S-EpoB acyl
enzyme that is the acceptor for acetyl-S-ACP. The holo
form of the PCP domain of the EpoB protein was gener-
ated after puri¢cation by using the Sfp for a second time,
but in this case with its natural cosubstrate CoASH, to
yield the phosphopantetheinylated PCP domain.
The functions of the Cy and Ox domains of EpoB could
then be assessed in the acetyl transfer/condensation assays.
Covalent transfer of the [3H]acetyl label from [3H]acetyl-
S-ACP to Cys-S-EpoB (but not to holo EpoB, see Fig.
7A) validated that the Cy domain was functional, at least
in amide bond-forming condensation mode. We have else-
where established that such Cy domains in pyochelin syn-
thetase [21] and yersiniabactin synthetase [26^28] are also
cyclodehydration catalysts, producing thiazoline rings
from acyl-Cys-S-enzyme intermediates. Given the evidence
that acetyl-S-ACP and [35S]Cys-S-EpoB incubation accu-
mulate the methylthiazolylcarboxy-S-EpoB (Fig. 7B), then
this Cy domain is also a heterocyclization catalyst on the
presumed initial N-Ac-Cys-S-EpoB condensation product
(Fig. 9B). The remaining domain of EpoB, the C-terminal
oxidase with its FMN cofactor should act as an ole¢n-
forming desaturase, akin to £avoprotein acyl-CoA desa-
turases or dihydroorotate dehydrogenases [9,29]. In this
case such desaturase action will convert the methylthiazo-
linylcarboxy-S-EpoB to the heteroaromatic thiazolylcar-
boxy-S-EpoB, completing the morphing transformation
of the initial Cys-S-EpoB acyl enzyme (Fig. 9B).
This condensation, cyclization, dehydration, oxidation
chemical sequence on the acyl-S-EpoB intermediates is
stoichiometric in the absence of the downstream assembly
line components, e.g. EpoC, so structural analysis required
release of the acyl thioesters by alkaline hydrolysis to
cleave the small molecules from the 150-kDa EpoB pro-
tein. HPLC analysis of the radioactive product and sepa-
rate mass spectroscopic evaluation established that only
2-methylthiazolyl-4-carboxylate and no 2-methylthiazolin-
yl-4-carboxylate or N-acetyl-cysteinyl intermediate was de-
tected (Fig. 7B). Separate controls established that authen-
tic 2-methylthiazolinyl-4-carboxylate was largely intact
under these work up conditions but did open partially to
N-Ac-Cys. Since no N-Ac-Cys was detected in release
from the EpoB incubations, we assume there was no meth-
ylthiazolinylcarboxy-S-enzyme species. These results con-
¢rm that the Ox domain is functional, and suggests that
cognate Ox domains in the myxothiazol and bleomycin
synthetase clusters [5,10] will have comparable conjugated
ole¢nic thioester-forming activities.
This work establishes that reconstitution of the PKS/
NRPS switch point in the epothilone assembly line has
been achieved in the acetyl-S-ACP/cysteinyl-S-EpoB incu-
bations and sets the stage for subsequent kinetic and
mechanistic analysis of the catalytic parameters for this
PKS/NRPS interface to make PK/NRP hybrid molecules.
The kinetic analysis of the ACP-EpoB incubation was not
being performed due to the rapid nature of acetyl group
transfer (data not shown), indicating that future kinetic
study will require chemical rapid-quench techniques. One
initial constraint is that the acetyl donor moiety must be
presented on the holo-ACP platform since acetyl-SNAC (a
very poor substrate, data not shown) and acetyl-CoA did
not serve as competent substrates, supporting a subunit/
subunit interface recognition for catalysis of chain trans-
fer. Subsequent work will evaluate whether heterologous
ACP domains can serve as the acyl donor platform which
will have implications for domain swapping in combina-
torial reconstruction of the epothilone assembly line with
di¡erent acyl starter units. Initial results indicate that
EpoB will not recognize an ACP domain excised from
the rapamycin gene cluster [30], suggesting that a level
of speci¢city exist in the protein-protein interaction across
the PKS/NRPS interface. Our strategy of bypassing the
constraints of the KS and AT domains of the EpoA sub-
unit by priming the puri¢ed apo-ACP domain with Sfp
and di¡erent acyl-S-pantP moieties gives an initial evalua-
tion of the permissivity of the EpoB Cy domain for acyl
group variation in condensation and heterocyclization and
of the Ox domain for alkylthiazolinyl-S-enzyme desatura-
tion tolerance. It has been reported that the phenylthia-
zolyl variant of epothilone, made by total synthesis retains
25% of its cell killing activity [31], so combinatorial
biosynthesis to produce altered heterocyclic caps to the
PK moiety of epothilones may be a viable approach for
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generating production quantities of novel epothilone hy-
brids.
4. Signi¢cance
In this report we have reconstituted the initial steps for
the biogenesis of epothilone D, a promising anticancer
drug with a similar mode of action as Taxol but possesses
some superior pharmacological properties. We have inves-
tigated the acyl group transfer across the ¢rst PKS/NRPS
interface and subsequent reactions e¡ected by the NRPS
module EpoB leading to the methylthiazole moiety forma-
tion. The putative oxidase was validated for the ¢rst time
to be a FMN-dependent acyl 2,3-desaturase to convert
thiazoline to thiazole, a function relevant to the biosyn-
theses of other thiazole-containing natural products such
as bleomycin. Our ¢ndings that the Cy and the Ox do-
mains in EpoB have relaxed substrate speci¢city toward
upstream acyl donors would promote future work to cre-
ate epothilone analogs with engineered loading modules
through genetic manipulation.
5. Materials and methods
5.1. General
Competent cells of E. coli strain top10 and BL21(DE3) were
purchased from Invitrogen. All restriction endonucleases and T4
DNA ligase were purchased from New England Biolabs. Oligo-
nucleotides were ordered from IDT and used without further
puri¢cation. The PPTase Sfp was expressed and puri¢ed as pre-
viously described [14]. [3H]acetyl-CoA and [35S]L-cysteine was
purchased from New England Nuclear. All acyl-CoA derivatives
were purchased from Sigma. DNA sequencing and MALDI-MS
was performed at the Dana Farber Cancer Institute.
5.2. Cloning of ACP domain of epoA (residues 1286^1421) and
full-length epoB gene
The ACP domain of epoA and full-length epoB genes were
ampli¢ed by PCR from a plasmid containing the EpoA,B,C genes
(provided by Kosan Biosciences) [32] with the following primer
pairs (acpNtermNdeI, 5P-G GAA TTC CAT ATG GCA GGC
GCC GGC CCG TCC ACC-3P, and acpCtermEcoRI, 5P-TTT
GAA TTC TCA TAG GGC AAT GAT TTC CCA-3P ; epoBN-
termNdeI, 5P-G GAA TTC CAT ATG ACC ATC AAC CAG
CTT CTG AA-3P, and epoBCtermNotI, 5P-G GGA ATT AGC
GGC CGC TTA GCT ACG TCT CCT GCC-3P). Restriction
sites introduced into the N- and C-terminal portions of the genes
are highlighted in the primer sequence in bold. Ampli¢ed prod-
ucts were puri¢ed by agarose gel, digested with the appropriate
restriction enzymes, and ligated into pET28b to provide the
N-terminal His6-tagged construct. DNA sequencing con¢rmed
the correct insertion of each gene into the plasmid, and the re-
sulting plasmids were transformed separately into BL21(DE3)
cells for protein overexpression.
5.3. Overexpression and puri¢cation of EpoA-ACP protein
For overproduction of ACP protein, cells harboring the desired
plasmid were grown in LB medium supplemented with 30 Wg/ml
of kanamycin. Cultures (3U1 l) were grown to an OD600 of 0.55
at 37‡C, cooled to 24‡C, and protein expression induced by the
addition of 100 WM IPTG. Cultures were grown for an additional
3 h. The harvested cells were then resuspended in 30 ml of lysis
bu¡er (25 mM Tris, pH 8.0, 200 mM NaCl, 10% (v/v) glycerol)
and lysed by French Press. The lysate was clari¢ed by centrifu-
gation (30 min at 35 000Ug) and promptly applied to 2 ml of
Ni^NTA resin (Qiagen). After binding in batch for 2 h at 4‡C,
the resin was decanted into a column, washed with 15 column
volumes of lysis bu¡er, and then eluted with a step gradient of 30,
60, 100, 250 and 500 mM imidazole. After analysis by SDS^
PAGE, fractions containing protein were pooled, dialyzed against
25 mM Tris, pH 8.0, 200 mM NaCl, 10% (v/v) glycerol, and
stored at 380‡C. ACP protein concentration was assessed using
the Bradford assay (Bio-Rad).
5.4. Overexpression and puri¢cation of EpoB protein
To overexpress EpoB protein, BL21(DE3) strains carrying the
desired plasmid were cultivated (6U1 l) in 2UYT broth contain-
ing 50 Wg/ml of kanamycin at 15‡C without adding IPTG to
induce protein production. After 72 h of growth, cells were har-
vested by centrifugation (10 min at 6000Ug), resuspended in
100 ml of lysis bu¡er (25 mM Tris, 200 mM NaCl, 2.5 mM
imidazole, pH 8.0), disrupted by two passages of French Press.
Cell lysate was clari¢ed by centrifugation (30 min at 35 000Ug).
The EpoB protein was ¢rst extracted from the crude cell lysate
using 25 ml Ni^NTA resin in batch binding fashion at 4‡C for 4 h.
After packing the Ni^NTA resin slurry into a column, the col-
umn was washed with 10 bed volumes of wash bu¡er (25 mM
Tris, 200 mM NaCl, 10 mM imidazole, pH 8.0) and EpoB pro-
tein was eluted with 200 mM imidazole. The second chromato-
graphic step was FPLC-MonoQ (Pharmacia) with a linear elution
pro¢le of 50^500 mM NaCl salt gradient over 270 ml. The £ow
rate was set at 3 ml/min and fractions of 3 ml were collected.
Fractions containing EpoB, as judged by SDS^PAGE, were
pooled, concentrated, and subjected to a size exclusion chromato-
graphic step with a HiLoad 16/60 Superdex 200 prep grade col-
umn (Pharmacia). The bu¡er was 25 mM Tris, 100 mM NaCl,
pH 7.5 and the £ow rate was 0.8 ml/min. Fractions (0.8 ml in
size) containing EpoB were pooled, dialyzed against 20 mM Tris,
pH 7.5, 50 mM NaCl, 1 mM DTT, and 10% glycerol, concen-
trated, and stored at 380‡C until use.
5.5. Modi¢cation of EpoA-ACP with Acyl-CoA
Reaction conditions were identical for each of the acyl-CoA
derivatives. In a representative example, EpoA-ACP (0.75 nmol)
was incubated with acetyl-CoA (3^5 fold molar excess) in 50 Wl
bu¡er (50 mM Tris, pH 7.0, 5 mM MgCl2, 5 mM tris(2-carboxy-
ethyl)phosphine hydrochloride (TCEP), 40 mM NaCl). The reac-
tion was initiated by the addition of Sfp (70 nM) and allowed
to incubate at ambient temperature (24‡C). Reaction progresses
were monitored either by TCA precipitation and liquid scintilla-
tion counting assays for the radiolabeled acyl-CoAs or by HPLC.
In the case of radiolabeled [3H]acetyl-CoA (28.3 Ci/mmol), the
reaction was quenched by the addition of 10% TCA. BSA (100
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Wg) was added as a carrier protein, and the precipitated proteins
were centrifuged, and washed twice with 10% TCA. The protein
pellet was resuspended in 100 Wl of formic acid and the amount of
radiolabel incorporation into the ACP was quanti¢ed by liquid
scintillation counting. Alternatively, the reaction was analyzed by
autoradiography to assure the speci¢c labeling of the ACP pro-
tein. A fraction of the reaction mixture (10 Wl) was used for
electrophoresis on a 15% SDS^PAGE. A control lacking Sfp
was also carried out. The gel was stained with Coomassie blue
solution, destained, and soaked in Amplify (Amersham) for 15
min. The dried gel was exposed to ¢lm for 14 h at 380‡C. Re-
actions performed with unlabeled acetyl-CoA were analyzed by
injecting a small amount of sample into HPLC with a Vydac C18
reverse phase column (linear gradient from 40% to 60% MeCN in
water containing 0.1% TFA over 30 min).
5.6. Characterization of the A and PCP domains of EpoB
to generate a L-cysteinyl-S-EpoB intermediate
5.6.1. ATP^PPi exchange assay for A domain substrate speci¢city
of EpoB
Reactions (100 Wl) containing 75 mM Tris (pH 7.5), 10 mM
MgCl2, 5 mM TCEP, 3 mM ATP, 1.5 mM of amino acid sub-
strate, 200 nM EpoB, and 1 mM [32P]pyrophosphate (3.6 Ci/mol)
were carried out at 24‡C. Following the initiation by the addition
of EpoB, reactions were allowed to proceed for 7 min, and then
quenched with charcoal suspensions (500 Wl of 1.6% (w/v) acti-
vated charcoal, 4.5% (w/v) tetrasodium pyrophosphate, and 3.5%
perchloric acid in water). The charcoal was pelleted by centrifu-
gation, washed twice with quenching bu¡er without added char-
coal, resuspended in 0.8 ml of water, and subjected to liquid
scintillation counting. The amount of bound radioactivity was
converted to reaction rate using the speci¢c radioactivity of the
[32P]pyrophosphate and the length of reaction time. To determine
kinetic parameters of L-Cys, reaction were carried out at 24‡C in
total volume of 100 Wl that contained 75 mM Tris^HCl (pH 7.5),
10 mM MgCl2, 5 mM TCEP, 3 mM ATP, 50 nM of EpoB, 1 mM
[32P] pyrophosphate, and various amount of L-Cys for 5 min.
For the incubations of (S)-2-aminobutyrate, 0.5 WM EpoB was
used and the reactions were allowed to continue for 10 min at
24‡C, while 0.5 WM EpoB was used for 10 min incubations for
L-Thr.
5.6.2. Assays for auto-aminoacylation of [35S]L-Cys to the PCP
domain of EpoB
EpoB was ¢rst primed with Sfp to install the pantP group on
the PCP domain. The speci¢c loading of [35S]L-Cys to the PCP
domain of EpoB was ¢rst investigated by autoradiography. In-
cubation mixture (50 Wl) included 75 mM Tris (pH 7.5), 10 mM
MgCl2, 0.25 mM [35S]Cys (10 Ci/mmol), 5 mM TCEP, 3 mM
ATP, and 3 WM of EpoB. The reaction was allowed to proceed
for 30 min at 24‡C and 15 Wl was used for electrophoresis on 10%
SDS^PAGE. Control reactions were carried out in parallel in
which either the ATP was omitted or EpoB was used without
Sfp treatment. For visualization, the gel was stained with Coo-
massie blue solution, destained, and soaked in Amplify for
15 min. The dried gel was exposed to ¢lm for 15 h before devel-
oping. The time course of the auto-aminoacylation was then ex-
amined using TCA precipitation assay. Reactions of 100 Wl in
volume contained 75 mM Tris (pH 7.5), 10 mM MgCl2, 5 mM
TCEP, 0.3 mM CoA, 0.2 WM Sfp, 3 WM EpoB, 0.25 mM [35S]L-
Cys (90 Ci/mol), and 3 mM ATP, and were incubated for 30 min
at 24‡C to allow the phosphopantetheinylation of the PCP do-
main prior to initiation by the addition of ATP. After addition of
ACP, aliquots of 10 Wl were withdrawn at various time points,
quenched with 0.5 ml of 10% TCA, and the precipitated protein
was pelleted, washed, and counted for radioactivity. Percent ami-
noacylation was calculated from the speci¢c activity of the [35S]L-
Cys and the EpoB concentration.
5.7. Characterization of the Cy and Ox domains of EpoB
5.7.1. Analysis of the acetyl group transfer from EpoA-ACP to
EpoB by autoradiography
EpoA-ACP (0.45 nmol) was primed with [3H]acetyl-CoA (28.3
Ci/mmol) as described above. EpoB (0.15 nmol) was primed with
free CoA and then loaded with L-Cys as described. The two
reaction solutions were then combined and allowed to incubate
at 24‡C for 60 min. Control reactions in which either ATP or
L-Cys was omitted were also performed. Non-reducing protein
sample bu¡er was then added to the solution and a fraction of
the sample was loaded and resolved on a 10% SDS^PAGE gel.
The gel was stained with Coomassie, destained, soaked in Am-
plify for 15 min and then dried. The gel was exposed to ¢lm for
48 h at 380‡C.
5.7.2. Identi¢cation EpoA-ACP and EpoB reaction product by
HPLC and mass spectrometric analysis
Acetyl-S-ACP and [35S]Cys-S-EpoB (2.6 Ci/mmol) were incu-
bated together as described above. The reaction was quenched by
the addition of 10% TCA, and precipitated protein was pelleted
by centrifugation and was then washed twice with 10% TCA. The
protein pellet was then dissolved in 50 Wl KOH (0.1 M) and
heated to 65‡C for 5 min. Tri£uoroacetic acid (50%, 10 Wl) was
then added, the solution centrifuged to remove precipitated pro-
teins, and the supernatant injected directly onto a HPLC
equipped with a Vydac C18 reverse phase column using a linear
gradient of 0^75% acetonitrile in water (containing 0.1% TFA)
over 30 min. For coinjection experiments, non-radiolabeled stan-
dard compounds were mixed with the reaction eluate and then
subjected to HPLC analysis. Dual on-line UV (at 220 nm) and
radioactivity detectors (tuned for 35S) were used to monitor the
retentions of the standards and the radioactive enzymatic prod-
uct, respectively.
A larger scale incubation (2 ml) contained 75 mM Tris (pH
7.5), 10 mM MgCl2, 3 mM ATP, 5 mM TCEP, 0.5 mM L-Cys,
5 WM holo EpoB, 5 WM acetyl-S-ACP. The incubation proceeded
for 30 min at 24‡C for aminoacylation of EpoB with L-Cys prior
to the addition of acetyl-S-ACP to initiate acetyl group transfer.
The work up procedure noted above for radioactive incubations
was followed. A peak having the same rt as the authentic meth-
ylthiazolyl carboxylate was collected from HPLC, lyophilized,
and subjected to MALDI-TOF-MS analysis.
5.7.3. Investigation of the substrate speci¢city of Cy and
Ox domains in EpoB
To investigate the substrate speci¢city of the Cy and Ox do-
mains in EpoB, various acyl groups were loaded onto EpoA-ACP
and tested as potential substrates for acyl transfer reaction across
the PKS/NRPS interface and subsequent cyclization/dehydration
and oxidation reactions. Some selected acyl-S-ACPs, acetoacetyl,
propionyl, butyryl, isobutyryl, isovaleryl, hexanoyl, and benzoyl
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were each mixed with [35S]Cys-EpoB under similar conditions
described above for the acetyl derivative. After 60 min incubation
at 24‡C, reactions were quenched, worked up, and analyzed by
radio-HPLC as described above.
5.7.4. Chemical syntheses of HPLC standards
Since EpoB reaction is a single turnover event without the
presence of the downstream modules, standards were prepared
to elucidate the structure of the enzymatic products. There are
three possible outcomes for every single acyl-EpoA-ACP sub-
strate, i.e. the open form N-acyl-cysteine, the cyclized alkylthiazo-
line carboxylate, and the oxidized alkylthiazole carboxylate, de-
pending on which functions of EpoB are operating. A general
synthetic route was envisioned to produce all three structures
along the way. A reported procedure to make 2-(2P-hydroxyphen-
yl)-2-thiazolines from 2-cyanophenol and L-cysteine [33] was
modi¢ed to make N-acyl-cysteines, which can be readily con-
verted to cyclized thiazoline, and further to the oxidized 2-al-
kylthiazolyl-4-carboxylic acids [34]. A representative case is
described here for synthesizing N-acetyl-cysteine, 2-methylthiazo-
linyl-4-carboxylate, and 2-methylthiazolyl-4-carboxylate. L-cys-
teine hydrochloride (6.5 g, 41.2 mmol) was dissolved in 250 ml
of degassed solution of MeOH: 0.1 M phosphate bu¡er. After
the pH of the solution was adjusted to V6, 20 ml of acetonitrile
was added and the resulting solution was re£uxed for 24 h under
N2 atmosphere. MeOH was removed under reduced pressure, the
resulting solution was cooled in an ice-bath and the pH adjusted
to V2.5 with concentrated phosphoric acid. Then the product
was extracted with CH2Cl2, dried (MgSO4), and concentrated in
vacuo to a¡ord N-acetyl-cysteine as a white solid (65% yield,
4.4 g). 1H NMR (DMSO, 200 MHz) N 1.85 (3H, s), 2.38 (1H,
t, J = 8.4 Hz, -SH), 2.63^2.86 (2H, m), 4.36 (1H, ddd, J = 7.8, 5.2,
4.8 Hz), 8.14 (1H, J = 7.8 Hz, N-H). MALDI-TOF calculated for
C5H9NO3S (M+H) 164.03; found 164.04.
To a solution of dry benzene (20 ml) and TFA (1 ml) was
added N-acetyl-cysteine (1 g) and the resulting mixture was
heated to re£ux under N2 atmosphere overnight. The solvent
was then removed by rotaevaporator, the residue was taken up
in 200 ml CH2Cl2, the organic phase washed with 100 mM phos-
phate bu¡er (pH 2.5), dried (MgSO4), and concentrated in vacuo
to a¡ord 2-methylthiazolinyl-4-carboxylic acid in quantitative
yield. MALDI-TOF calculated for C5H7NO2S (M+H) 146.01;
found 146.04. Oxidation was achieved by adding ¢ve equivalents
of MnO2 to the methylene chloride solution of the thiazoline
compound and the reaction was allowed to proceed at 24‡C
with vigorous magnetic stirring. After 48 h, the mixture was ¢l-
tered through a pad of Celite and concentrated in vacuo to give
the oxidized product. When the purity was not satisfactory, the
¢nal product was further puri¢ed by HPLC with a prep C18
column using a linear gradient of acetonitrile in water (contained
0.1% TFA) from 0 to 70% over 30 min. 1H NMR (CDCl3,
200 MHz) N 2.79 (3H, s), 8.15 (1H, s), 10.91 (1H, s, ^COOH),
MALDI-TOF calculated for C5H5NO2S (M+H) 144.01; found
144.01. NMR and mass data for 2-phenylthiazolyl-4-carboxylic
acid, 1H NMR (CDCl3, 200 MHz) N 7.51 (3H, m), 7.98 (2H, m),
8.26 (1H, s), MALDI-TOF C10H7NO2S (M+H) calculated
206.03; found 206.08. MALDI-TOF mass data of other thiazolyl
carboxylic acids are listed below: 2-pentylthiazolyl-4-carboxylic
acid, C9H13NO2S (M+H) calculated 200.07; found 199.99.
2-Isobutylthiazolyl-4-carboxylic acid, C8H11NO2S (M+H) cal-
culated 186.06; found 186.96. 2-Isopropylthiazolyl-4-carboxylic
acid, C7H9NO2S (M+H) calculated 172.04; found 186.01.
2-Propylthiazolyl-4-carboxylic acid, C7H9NO2S (M+H) calcu-
lated 172.04; found 186.00. 2-Ethytlthiazolyl-4-carboxylic acid,
C6H7NO2S (M+H) calculated 158.03; found 157.97.
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